Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05937308 · ClinicalTrials.gov registry record · NA

NEUROMARK Registry Study

A NA study of Chronic Rhinitis, sponsored by Neurent Medical.

Active
Registry status
NA
Development phase
150
Enrollment target
7
Study locations

NCT05937308 is a NA study of Chronic Rhinitis that is active but no longer recruiting, run by Neurent Medical. The registered enrollment target is 150 participants, above the 72-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (108% higher). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05937308, a NA study of Chronic Rhinitis, is active but no longer recruiting, sponsored by Neurent Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
7
Study locations

Study Summary

The NEUROMARK Registry Study is a prospective, multicenter, single-arm, post-market, interventional registry study to collect real-world evidence of the NEUROMARK System in subjects with chronic rhinitis.

Conditions Studied

Interventions

  • DEVICE NEUROMARK System

Study Locations (7)

California

  • Sensa Health - Los Angeles
  • Sacramento ENT - Roseville

Alabama

  • Alabama Nasal & Sinus Center - Birmingham

Florida

  • Florida ENT & Allergy - Brandon

Texas

  • ENT & Allergy Texas - McKinney

Utah

  • Ogden Clinic - Ogden

Virginia

  • Metropolitan ENT - Alexandria

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-06-12
Est. Completion 2027-09
Phase NA

Sponsor

Neurent Medical

5 total trials

What the Registry Record Tells You About NCT05937308

The ClinicalTrials.gov registry entry for NCT05937308 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 72-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (108% higher). The listed sponsor is Neurent Medical, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Rhinitis appearing as the primary indexed condition, and to 1 intervention - of which NEUROMARK System is the first listed.

NCT05937308 reports 7 study locations spanning 6 distinct geographic areas - top geographies include California, Alabama, Florida.

Frequently Asked Questions

What is clinical trial NCT05937308 about?

NCT05937308 is a clinical study titled "NEUROMARK Registry Study". The NEUROMARK Registry Study is a prospective, multicenter, single-arm, post-market, interventional registry study to collect real-world evidence of the NEUROMARK System in subjects with chronic rhinitis.

What is the current status of trial NCT05937308?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-06-12. Estimated completion is 2027-09.

What conditions does trial NCT05937308 study?

This clinical trial studies the following conditions: Chronic Rhinitis.

What interventions are being tested in trial NCT05937308?

The interventions under investigation include: NEUROMARK System (DEVICE).

Who is sponsoring clinical trial NCT05937308?

This trial is sponsored by Neurent Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05937308 being conducted?

This trial has 7 study locations across Alabama, California, Florida, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Rhinitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.